Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Infection|January 1, 1979
[The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin, tetracycline and co-trimoxazole (author's transl)]K MachkaArzneimittel-Forschung|January 1, 1980
[In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)]I Braveny, K MachkaEuropean Journal of Clinical Microbiology|October 1, 1983
Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicinK Machka, R DietzEuropean Journal of Clinical Microbiology|August 1, 1983
In vitro activity of HR 810, a new broad-spectrum cephalosporinK Machka, I BravenyEuropean Journal of Clinical Microbiology|February 1, 1987
Serum bactericidal activity of ciprofloxacin and ofloxacin in volunteersK Machka, D MilatovicEuropean Journal of Clinical Microbiology|August 1, 1987
Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivativeK Machka, I BravenyEuropean Journal of Clinical Microbiology|February 1, 1987
Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocciK Machka, I BravenyEuropean Journal of Clinical Microbiology|August 1, 1982
Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillinK Machka, W Baierl, I BravenyArzneimittel-Forschung|January 1, 1980
In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillinK Machka, H Dickert, I BravenyEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of new antibiotics against Haemophilus influenzaeK Machka, H Balg, I BravenyPageof 4